293 related articles for article (PubMed ID: 34156450)
1. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer.
Li X; Zheng NR; Wang LH; Li ZW; Liu ZC; Fan H; Wang Y; Dai J; Ni XT; Wei X; Liu MW; Li K; Li ZX; Zhou T; Zhang Y; Zhang JY; Kadeerhan G; Huang S; Wu WH; Liu WD; Wu XZ; Zhang LF; Xu JM; Gerhard M; You WC; Pan KF; Li WQ; Qin J
EBioMedicine; 2021 Dec; 74():103714. PubMed ID: 34818622
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study.
Liu ZC; Wu WH; Huang S; Li ZW; Li X; Shui GH; Lam SM; Li BW; Li ZX; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
Theranostics; 2022; 12(10):4671-4683. PubMed ID: 35832080
[No Abstract] [Full Text] [Related]
4. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
6. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.
Fan H; Li X; Li ZW; Zheng NR; Cao LH; Liu ZC; Liu MW; Li K; Wu WH; Li ZX; Zhou T; Zhang Y; Liu WD; Zhang LF; You WC; Wang Y; Wu J; Pan KF; Qin J; Li WQ
EBioMedicine; 2022 Dec; 86():104340. PubMed ID: 36356476
[TBL] [Abstract][Full Text] [Related]
7. [The risk of incident gastric cancer for populations with different precancerous gastric lesions: a prospective follow-up study].
Wu XZ; Liu ZC; Qin XX; Li Y; Zhang LF; Li ZX; Zhang Y; Zhou T; Zhang JY; Liu WD; You WC; Pan KF; Li WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Dec; 43(12):1972-1978. PubMed ID: 36572472
[No Abstract] [Full Text] [Related]
8. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
9. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.
Zhang LY; Zhang J; Li D; Liu Y; Zhang DL; Liu CF; Wang N; Wu SR; Lu WQ; Guo JZ; Shi YQ
J Dig Dis; 2021 May; 22(5):282-290. PubMed ID: 33793080
[TBL] [Abstract][Full Text] [Related]
10. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
[TBL] [Abstract][Full Text] [Related]
11. Associations of the -238(G/A) and -308(G/A) TNF-α Promoter Polymorphisms and TNF-α Serum Levels with the Susceptibility to Gastric Precancerous Lesions and Gastric Cancer Related to Helicobacter pylori Infection in a Moroccan Population.
Bounder G; Jouimyi MR; Boura H; Touati E; Michel V; Badre W; Jouhadi H; Kadi M; Eljihad M; Benomar H; Kettani A; Lebrazi H; Maachi F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1623-1629. PubMed ID: 32592356
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population.
Boreiri M; Samadi F; Etemadi A; Babaei M; Ahmadi E; Sharifi AH; Nikmanesh A; Houshiar A; Pourfarzai F; Yazdanbod A; Alimohammadian M; Sotoudeh M
Arch Iran Med; 2013 Jun; 16(6):343-7. PubMed ID: 23725067
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between RUNX3 expression and precancerous gastric lesions in high-risk population].
Li WQ; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Li JY; Wang Z; Su Y; You WC
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):348-52. PubMed ID: 19727221
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.
You WC; Zhang L; Gail MH; Ma JL; Chang YS; Blot WJ; Li JY; Zhao CL; Liu WD; Li HQ; Hu YR; Bravo JC; Correa P; Xu GW; Fraumeni JF
Int J Epidemiol; 1998 Dec; 27(6):941-4. PubMed ID: 10024185
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
17. Association Between Lifestyle Factors, Vitamin and Garlic Supplementation, and Gastric Cancer Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
Guo Y; Li ZX; Zhang JY; Ma JL; Zhang L; Zhang Y; Zhou T; Liu WD; Han ZX; Li WQ; Pan KF; You WC
JAMA Netw Open; 2020 Jun; 3(6):e206628. PubMed ID: 32589229
[TBL] [Abstract][Full Text] [Related]
18. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
Valenzuela MA; Canales J; Corvalán AH; Quest AF
World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
